Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

被引：197
|
作者：
Takashita, Emi [1 ]
Kinoshita, Noriko [2 ]
Yamayoshi, Seiya [3 ]
Sakai-Tagawa, Yuko [3 ]
Fujisaki, Seiichiro [1 ]
Ito, Mutsumi [3 ]
Iwatsuki-Horimoto, Kiyoko [3 ]
Halfmann, Peter [4 ]
Watanabe, Shinji [1 ]
Maeda, Kenji [2 ]
Imai, Masaki [3 ]
Mitsuya, Hiroaki [2 ]
Ohmagari, Norio [2 ]
Takeda, Makoto [1 ]
Hasegawa, Hideki [1 ]
Kawaoka, Yoshihiro [3 ]
机构：
[1] Natl Inst Infect Dis, Tokyo, Japan
[2] Natl Ctr Global Hlth & Med, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Wisconsin, Madison, WI USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 15期
关键词：
D O I：
10.1056/NEJMc2201933
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1475 / 1477
页数：3
相关论文
共 50 条
  • [31] T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA)
    Li, Hu
    Chen, Zhiwei
    Liu, Xiaoqing
    Hu, Peng
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4591 - 4592
  • [32] In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
    Takashita, Emi
    Yamayoshi, Seiya
    Halfmann, Peter
    Wilson, Nancy
    Ries, Hunter
    Richardson, Alex
    Bobholz, Max
    Vuyk, William
    Maddox, Robert
    Baker, David A.
    Friedrich, Thomas C.
    O'Connor, David H.
    Uraki, Ryuta
    Ito, Mutsumi
    Sakai-Tagawa, Yuko
    Adachi, Eisuke
    Saito, Makoto
    Koga, Michiko
    Tsutsumi, Takeya
    Iwatsuki-Horimoto, Kiyoko
    Kiso, Maki
    Yotsuyanagi, Hiroshi
    Watanabe, Shinji
    Hasegawa, Hideki
    Imai, Masaki
    Kawaoka, Yoshihiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (22): : 2094 - 2097
  • [33] Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
    Ohashi, Hirofumi
    Hishiki, Takayuki
    Akazawa, Daisuke
    Kim, Kwang Su
    Woo, Joohyeon
    Shionoya, Kaho
    Tsuchimoto, Kana
    Iwanami, Shoya
    Moriyama, Saya
    Kinoshita, Hitomi
    Yamada, Souichi
    Kuroda, Yudai
    Yamamoto, Tsukasa
    Kishida, Noriko
    Watanabe, Shinji
    Hasegawa, Hideki
    Suzuki, Tadaki
    Maeda, Ken
    Fukushi, Shuetsu
    Takahashi, Yoshimasa
    Iwami, Shingo
    Watashi, Koichi
    ANTIVIRAL RESEARCH, 2022, 205
  • [34] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Jing Zou
    Chaitanya Kurhade
    Hongjie Xia
    Mingru Liu
    Xuping Xie
    Ping Ren
    Pei-Yong Shi
    Nature Communications, 13
  • [35] Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters
    Machado, Rafael R. G.
    Walker, Jordyn L.
    Scharton, Dionna
    Rafael, Grace H.
    Mitchell, Brooke M.
    Reyna, Rachel A.
    de Souza, William M.
    Liu, Jianying
    Walker, David H.
    Plante, Jessica A.
    Plante, Kenneth S.
    Weaver, Scott C.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [36] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Zou, Jing
    Kurhade, Chaitanya
    Xia, Hongjie
    Liu, Mingru
    Xie, Xuping
    Ren, Ping
    Shi, Pei-Yong
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [37] Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters
    Rafael R. G. Machado
    Jordyn L. Walker
    Dionna Scharton
    Grace H. Rafael
    Brooke M. Mitchell
    Rachel A. Reyna
    William M. de Souza
    Jianying Liu
    David H. Walker
    Jessica A. Plante
    Kenneth S. Plante
    Scott C. Weaver
    Nature Communications, 14
  • [38] Real-World Effectiveness of Sotrovimab in Patients Infected With SARS-CoV-2 Omicron Subvariant BA.2 in Western Sydney, Australia
    Kalo, Eric
    Basyouni, Ziad
    Katz, Gideon Meyerowitz
    Karkvandi, Vahid
    Watson, Leanne
    Crowther, Helen
    Read, Scott
    O'Sullivan, Matthew V. N.
    Ellis, Jasmin
    Medlin, Joanne
    Ahlenstiel, Golo
    JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (02)
  • [39] Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
    Zheng, Qianqian
    Duan, Liangwei
    Jiang, Zhihua
    Gu, Tingxuan
    Zhang, Bojie
    Li, Jiaoyang
    Zhang, Yang
    Zhang, Shiyu
    Liang, Yinming
    Wang, Hui
    GENES & DISEASES, 2023, 10 (03) : 664 - 667
  • [40] Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation
    Wang, Qian
    Li, Zhiteng
    Ho, Jerren
    Guo, Yicheng
    Yeh, Andre Yanchen
    Mohri, Hiroshi
    Liu, Michael
    Wang, Maple
    Yu, Jian
    Shah, Jayesh G.
    Chang, Jennifer Y.
    Herbas, Favio
    Yin, Michael T.
    Sobieszczyk, Magdalena E.
    Sheng, Zizhang
    Liu, Lihong
    Ho, David
    LANCET INFECTIOUS DISEASES, 2022, 22 (12): : 1666 - 1668
12345